Xiushan Yin

This study develops CAR-M2-FAP and CAR-M2-NCL therapies targeting FLS in RA and OA, showing reduced inflammation and joint damage in mouse models.

This paper introduces s5PSeq, a streamlined protocol for rapid antimicrobial sensitivity testing using 5P mRNA degradation intermediates, demonstrating its clinical utility in identifying resistant Clostridioides difficile isolates.

This paper introduces MEFI, a platform for iterative mRNA delivery that enhances expression and cross-organ transfer in mice.

This study evaluates PSMA-targeted CAR-Ms in preclinical models, showing tumor regression and safety in xenograft mice.